Skip to main content

Table 1.

Somatic mutations of class I β‐tubulin in human lung cancers and breast cancers

Authors Type of cancer No. tumors Frequency of mutation (%)
Monzo et al. ( 5 ) NSCLC 49 32.6 (16/49)
Kelley et al. ( 8 ) NSCLC 42  2.4 (1/42)
Tsurutani et al. ( 9 ) NSCLC 42  2.4 (1/42)
Maeno( 7 ) Breast cancer 82    0 (0/82)
Hasegawa et al. ( 6 ) Breast cancer 62  1.6 (1/62)

NSCLC, non‐small‐cell lung cancer.